PULMONX CORPORATION

PulmonX Corporation specializes in the design, development, and manufacturing of advanced endobronchial and cardiac implantable valves and custom surgical devices for clinical use in respiratory and cardiovascular interventions. Their technical expertise lies in minimally invasive pulmonary therapeutics, including bronchial valve systems and precision-engineered prosthetic implants, with a focus on biocompatible materials, anatomical adaptation, and implant delivery technologies. The company demonstrates deep specialization in patient-specific surgical solutions, integrating clinical feedback into iterative product development cycles to support complex airway and valvular repair applications. Their capability set includes regulatory-compliant manufacturing processes for Class III medical devices, sterile packaging, and traceability systems aligned with FDA and ISO 13485 standards. The Department of Veterans Affairs is the predominant federal partner, consistently procuring pulmonary and cardiac implant systems to support veteran-centric respiratory care programs. Work includes procurement of bronchial valves, endobronchial implants, and custom prosthetics tailored for post-surgical recovery and chronic obstructive pulmonary disease management, indicating a sustained, mission-driven relationship focused on improving long-term outcomes for veterans with advanced lung conditions. PulmonX operates primarily within NAICS 339112 and 339113, focusing on surgical instrument and appliance manufacturing for implantable medical devices. Their market positioning centers on high-acuity pulmonary interventions, distinguishing themselves through proprietary valve designs and patient-specific implant customization, serving a niche but critical segment of interventional pulmonology and cardiothoracic surgery. As a privately held entity headquartered in Redwood City, California, PulmonX Corporation is a specialized medical device manufacturer with no disclosed government certifications. Their geographic presence is centered in the U.S. biomedical innovation corridor, supporting federal healthcare procurement through direct manufacturing and clinical collaboration with VA medical centers and affiliated research institutions.